Sendero Wealth Management’s AbbVie ABBV Stock Holding History

Sendero Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.36M	Buy	9,395 +713	+8%	+$153K	0.24%	72
2026 Q1	$1.89M	Sell	8,682 -513	-6%	-$114K	0.21%	71
2025 Q4	$2.1M	Sell	9,195 -59	-0.6%	-$13.4K	0.23%	67
2025 Q3	$2.14M	Sell	9,254 -35	-0.4%	-$7.13K	0.25%	63
2025 Q2	$1.72M	Sell	9,289 -36	-0.4%	-$6.69K	0.22%	71
2025 Q1	$1.95M	Buy	9,325 +2,074	+29%	+$403K	0.27%	60
2024 Q4	$1.29M	Buy	7,251 +706	+11%	+$130K	0.19%	77
2024 Q3	$1.29M	Sell	6,545 -1,872	-22%	-$349K	0.2%	66
2024 Q2	$1.44M	Sell	8,417 -35	-0.4%	-$5.8K	0.24%	59
2024 Q1	$1.54M	Buy	8,452 +66	+0.8%	+$11.4K	0.26%	62
2023 Q4	$1.3M	Buy	8,386 +387	+5%	+$56.4K	0.25%	68
2023 Q3	$1.19M	Buy	7,999 +1	+0%	+$147	0.26%	68
2023 Q2	$1.08M	Buy	+7,998	New	+$1.17M	0.24%	75

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Sendero Wealth Management's ABBV Position: Q2 2026 in Review

Sendero Wealth Management increased its AbbVie (ABBV) stake by 8.2% in Q2 2026, buying an estimated $153K and bringing the position to 9,395 shares worth $2.36M. The position accounts for 0.24% of the portfolio, ranked #72.

Sendero Wealth Management first reported a position in ABBV in Q2 2023 and has held it in 13 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Sendero Wealth Management held 9,395 shares of AbbVie worth $2.36M as of Q2 2026.
Sendero Wealth Management bought 713 AbbVie shares in Q2 2026, an estimated $153K.
AbbVie made up 0.24% of Sendero Wealth Management's portfolio in Q2 2026, its #72 holding.
Sendero Wealth Management first reported a position in AbbVie in Q2 2023 and has held it in 13 quarters since.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Sendero Wealth Management's 13F filing for Q2 2026, filed 4 Aug 2026.